There is no doubt that early detection is closely linked to the best results for any disease, including those that affect your eyes, such as age-related macular degeneration (AMD). And at The Retina Group of Washington, we’re dedicated to prompt diagnosis, which then leads to more effective treatment, even in cases where a disease cannot actually be cured. And since we’ve been on the cutting edge of technology since our very beginnings, it comes at no surprise that we’re at the forefront again when it comes to Macula Risk Pgx, a state-of-the-art method for early detection of AMD and for predicting the effects of it.
Genetic testing has come a long way, and can now be put to use in so many vital ways. One such example is with Macula Risk Pgx. Our Edgewater ophthalmology office performs a simple, easy, painless cheek swab, which is then lab tested using this special process to determine the following: what your risk is of getting advanced AMD during various intervals over the course of a 10 year period; and whether you would be a good candidate for vitamin therapy as a way of preserving maximum vision in spite of AMD. This, as you may have surmised, is nothing short of a revolution in the care and management of AMD. Our Edgewater ophthalmology office wants to help you to keep your central vision for as long as possible. The disease is a degrading of the macula, the small part inside your retina. Over time, the center of your visual field is lost, leaving only vision on the sides. But thanks to various advancements, including this DNA testing, you can be prepared for the likely outcome and work with us to find methods of care that are applicable.
Macula Risk Pgx is not for everyone. Contact our Edgewater ophthalmology office to schedule an appointment and discover if it is right for you.